4DMedical Company Description
4DMedical Limited operates as a medical technology company in the United States and Australia.
The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging.
It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner.
The company was incorporated in 2012 and is based in Carlton, Australia.

Country | Australia |
Founded | 2012 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 124 |
CEO | Andreas Fouras |
Contact Details
Address: Melbourne Connect Carlton, 3053 Australia | |
Phone | 61 3 9545 5940 |
Website | 4dmedical.com |
Stock Details
Ticker Symbol | 4DX |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU0000095416 |
SIC Code | 7372 |
Key Executives
Name | Position |
---|---|
Dr. Andreas Fouras M.A.I.C.D., Ph.D. | Founder, MD, Chief Executive Officer and Director |
Matt Tucker | Chief Commercial Officer |
Chris Cox | Interim Chief Financial Officer and Financial Controller |
Beth Plunkett | Senior Legal Counsel |
Dr. Aidan Jamison B.E., Ph.D. | Senior Vice President of Engineering |
Rachael Tenkaten | Senior Vice President of Product |
Dr. Greg T. Mogel M.D. | Chief Medical Officer |
David Hannes B.S., M.B.A. | Senior Vice President of Global Business Development |